Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases

Leukemia

Volumn 16, Issue 3, 2002, Pages 299-305

  Vermeulen, K ^a   Strnad, M ^b   Krystof V ^b   Havli cek L ^b   Van der Aa, A ^a   Lenjou, M ^a   Nijs, G ^a   Rodrigus, I ^c   Stockman, B ^c   van Onckelen, H ^a   Van Bockstaele, D R ^a   Berneman, Z N ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anti cancer agents; Apoptosis; CDK inhibition; Cell proliferation; Cytokinin analogues; Olomoucine

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYL DERIVATIVE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYTOKININ; CYTOSTATIC AGENT; HYDROXYL GROUP; OLOMOUCINE; PLANT EXTRACT; PURINE DERIVATIVE;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL; TISSUE GROWTH;

EID: 85014148754     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402378     Document Type: Article

References (39)

1. Kinetin, a cell division factor from deoxyribonucleic acid
2. The aromatic cytokinins
3. Cytokinin activation of Arabidopsis cell division through a D-type cyclin
4. A low content in zeatin type cytokinins is not restrictive for the occurrence of G1/S transition in tobacco BY-2 cells
5. Cyclic activation of histone H1 kinase during sea urchin egg mitotic divisions
6. A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates
7. 6-Dimethylaminopurine blocks starfish oocyte maturation by inhibiting a relevant protein kinase activity
8. Inhibition of cyclin-dependent kinases by purine analogues
9. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases
10. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics
11. Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage
12. Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine
13. Inhibition of cyclin-dependent kinases by purine analogues: Crystal structure of human cdk2 complexed with roscovitine
14. Multiple modes of ligand recognition: Crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine
15. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5
16. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors
17. Cancer cell cycles
18. Genetic alterations of cyclins, cyclin-dependent kinases, and CDK inhibitors in human cancer
19. CDK inhibition and cancer therapy
20. Acute myelogenous leukemia: A human cell line responsive to colony-stimulating activity
21. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes
22. Cytokinin-derived cyclin-dependent kinase inhibitors: Synthesis and cdc2 inhibitory activity of olomoucine and related compounds
23. Quantitation of cell concentration using the flow cytometer
24. Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres
25. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells
26. CD34++ CD38- and CD34+CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source
27. Purification and partial characterization of a human hematopoietic precursor population
28. Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells
29. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis
30. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias
31. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents
32. Synthesis and application of functionally diverse 2, 6, 9-trisubstituted purine libraries as CDK inhibitors
33. Synthesis and in vitro evaluation of novel 2, 6, 9-trisubstituted purines acting as cyclin-dependent kinase inhibitors
34. Inhibition of lymphocyte proliferation by amantadine and its isomer, 2-aminoadamantane; impact on Lyt-2+ T cells while sparing L3T4+ T cells
35. Mechanisms of action of flavopiridol
36. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275
37. Preclinical and clinical development of cyclin-dependent kinase modulators
38. Chemical inhibitors of cyclin-dependent kinases
39. Properties and potential applications of chemical inhibitors of cyclin-dependent kinases